Fig. 3.
Transition of Tumor marker was linked with the treatment effect. EC epirubicin + cyclophosphamide, LET letrozole, PTX paclitaxel
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.